HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial

被引:11
作者
Fogel, Jessica M. [1 ]
Hudelson, Sarah E. [1 ]
Ou, San-San [2 ]
Hart, Stephen [3 ]
Wallis, Carole [4 ,5 ]
Morgado, Mariza G. [6 ]
Saravanan, Shanmugam [7 ]
Tripathy, Srikanth [8 ]
Hovind, Laura [3 ]
Piwowar-Manning, Estelle [1 ]
Sabin, Devin [1 ]
McCauley, Marybeth [9 ]
Gamble, Theresa [10 ]
Zhang, Xinyi C. [2 ]
Eron, Joseph J. [11 ]
Gallant, Joel E. [12 ]
Kumwenda, Johnstone [13 ]
Makhema, Joseph [14 ]
Kumarasamy, Nagalingeswaran [15 ]
Chariyalertsak, Suwat [16 ]
Hakim, James [17 ]
Badal-Faesen, Sharlaa [18 ]
Akelo, Victor [19 ]
Hosseinipour, Mina C. [20 ,21 ]
Santos, Breno R. [22 ]
Godbole, Sheela V. [23 ]
Pilotto, Jose H. [24 ,25 ]
Grinsztejn, Beatriz [26 ]
Panchia, Ravindre [27 ]
Mayer, Kenneth H. [28 ,29 ]
Chen, Ying Q. [30 ,31 ]
Cohen, Myron S. [11 ]
Eshleman, Susan H. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[2] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA
[3] Frontier Sci & Technol Res Fdn Inc, Amherst, NY USA
[4] Lancet Labs, Specialty Mol Div, Johannesburg, South Africa
[5] BARC SA, Johannesburg, South Africa
[6] Inst Oswaldo Cruz, Lab AIDS & Mol Immunol, BR-20001 Rio De Janeiro, Brazil
[7] YR Gaitonde Ctr AIDS Res & Educ, Chennai, Tamil Nadu, India
[8] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Agra, Uttar Pradesh, India
[9] FHI 360, Sci Facilitat Dept, Washington, DC USA
[10] FHI 360, Sci Facilitat Dept, Durham, NC USA
[11] Univ N Carolina, Dept Med, Chapel Hill, NC USA
[12] Southwest CARE Ctr, Santa Fe, NM USA
[13] Johns Hopkins Project, Coll Med, Blantyre, Malawi
[14] Botswana Harvard AIDS Inst, Gaborone, Botswana
[15] VHS, YRGCARE Med Ctr, Chennai, Tamil Nadu, India
[16] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand
[17] Univ Zimbabwe, Dept Med, Harare, Zimbabwe
[18] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa
[19] Ctr Dis Control, Kenya Med Res Inst, Kisumu, Kenya
[20] Univ N Carolina, Div Infect Dis, Chapel Hill, NC USA
[21] UNC Project Malawi, Inst Global Hlth & Infect Dis, Lilongwe, Malawi
[22] Hosp Nossa Senhora da Conceicao, Serv Infectol, Porto Alegre, RS, Brazil
[23] Natl AIDS Res Inst ICMR, Dept Epidemiol & Biostat, Pune, Maharashtra, India
[24] Hosp Geral de Nova Iguacu, Rio De Janeiro, Brazil
[25] Fiocruz MS, Lab AIDS & Imunol Mol IOC, BR-21045900 Rio De Janeiro, Brazil
[26] Fiocruz MS, Inst Nacl Infectol Evandro Chagas INI, BR-21045900 Rio De Janeiro, Brazil
[27] Univ Witwatersrand, Soweto HPTN CRS, Perinatal HIV Res Unit, Soweto, South Africa
[28] Fenway Inst, Fenway Hlth & Infect Dis Div, Boston, MA USA
[29] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA
[30] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA
[31] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA
基金
美国国家卫生研究院;
关键词
HIV; HPTN; 052; early ART; ART failure; resistance; CELL COUNTS; THERAPY; INFECTION; INITIATION; FAILURE; MUTATIONS;
D O I
10.1097/QAI.0000000000000951
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Early initiation of antiretroviral treatment (ART) reduces HIV transmission and has health benefits. HIV drug resistance can limit treatment options and compromise use of ART for HIV prevention. We evaluated drug resistance in 85 participants in the HIV Prevention Trials Network 052 trial who started ART at CD4 counts of 350-550 cells per cubic millimeter and failed ART by May 2011; 8.2% had baseline resistance and 35.3% had resistance at ART failure. High baseline viral load and less education were associated with emergence of resistance at ART failure. Resistance at ART failure was observed in 7 of 8 (87.5%) participants who started ART at lower CD4 cell counts.
引用
收藏
页码:304 / 309
页数:6
相关论文
共 22 条
  • [11] French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults
    Hoen, Bruno
    Bonnet, Fabrice
    Delaugerre, Constance
    Delobel, Pierre
    Goujard, Cecile
    L'Henaff, Marianne
    Persiaux, Renaud
    Rey, David
    Rouzioux, Christine
    Taburet, Anne-Marie
    Morlat, Philippe
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17
  • [12] STANDARDIZATION OF SENSITIVE HUMAN-IMMUNODEFICIENCY-VIRUS COCULTURE PROCEDURES AND ESTABLISHMENT OF A MULTICENTER QUALITY ASSURANCE PROGRAM FOR THE AIDS CLINICAL-TRIALS GROUP
    HOLLINGER, FB
    BREMER, JW
    MYERS, LE
    GOLD, JWM
    MCQUAY, L
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (07) : 1787 - 1794
  • [13] Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial
    Kantor, Rami
    Smeaton, Laura
    Vardhanabhuti, Saran
    Hudelson, Sarah E.
    Wallis, Carol L.
    Tripathy, Srikanth
    Morgado, Mariza G.
    Saravanan, Shanmugham
    Balakrishnan, Pachamuthu
    Reitsma, Marissa
    Hart, Stephen
    Mellors, John W.
    Halvas, Elias
    Grinsztejn, Beatriz
    Hosseinipour, Mina C.
    Kumwenda, Johnstone
    La Rosa, Alberto
    Lalloo, Umesh G.
    Lama, Javier R.
    Rassool, Mohammed
    Santos, Breno R.
    Supparatpinyo, Khuanchai
    Hakim, James
    Flanigan, Timothy
    Kumarasamy, Nagalingeswaran
    Campbell, Thomas B.
    Eshleman, Susan H.
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 60 (10) : 1541 - 1549
  • [14] Initiation of antiretroviral therapy at high CD4+ cell counts is associated with positive treatment outcomes
    Lima, Viviane D.
    Reuter, Anja
    Harrigan, P. Richard
    Lourenco, Lillian
    Chau, William
    Hull, Mark
    Mackenzie, Lauren
    Guillemi, Silvia
    Hogg, Robert S.
    Barrios, Rolando
    Montaner, Julio S. G.
    [J]. AIDS, 2015, 29 (14) : 1871 - 1882
  • [15] Web resources for HIV type 1 genotypic-resistance test interpretation
    Liu, TF
    Shafer, RW
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 (11) : 1608 - 1618
  • [16] Role of HIV Infection Duration and CD4 Cell Level at Initiation of Combination Anti-Retroviral Therapy on Risk of Failure
    Lodi, Sara
    Phillips, Andrew
    Fidler, Sarah
    Hawkins, David
    Gilson, Richard
    McLean, Ken
    Fisher, Martin
    Post, Frank
    Johnson, Anne M.
    Walker-Nthenda, Louise
    Dunn, David
    Porter, Kholoud
    [J]. PLOS ONE, 2013, 8 (09):
  • [17] Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
    Lundgren, Jens D.
    Babiker, Abdel G.
    Gordin, Fred
    Emery, Sean
    Sharma, Shweta
    Avihingsanon, An-Chalee
    Cooper, David A.
    Faetkenheuer, Gerd
    Llibre, Josep M.
    Moli-Na, Jean-Michel
    Munderi, Paula
    Schechter, Mauro
    Wood, Robin
    Klingman, Karin L.
    Collins, Simon
    Lane, H. Clifford
    Phillips, Andrew N.
    Neaton, James D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (09) : 795 - 807
  • [18] Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa
    Marconi, Vincent C.
    Sunpath, Henry
    Lu, Zhigang
    Gordon, Michelle
    Koranteng-Apeagyei, Kofi
    Hampton, Jane
    Carpenter, Steve
    Giddy, Janet
    Ross, Douglas
    Holst, Helga
    Losina, Elena
    Walker, Bruce D.
    Kuritzkes, Daniel R.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 (10) : 1589 - 1597
  • [19] Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti.
    Severe, Patrice
    Juste, Marc Antoine Jean
    Ambroise, Alex
    Eliacin, Ludger
    Marchand, Claudel
    Apollon, Sandra
    Edwards, Alison
    Bang, Heejung
    Nicotera, Janet
    Godfrey, Catherine
    Gulick, Roy M.
    Johnson, Warren D., Jr.
    Pape, Jean William
    Fitzgerald, Daniel W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03) : 257 - 265
  • [20] Antiretroviral Treatment of Adult HIV Infection 2012 Recommendations of the International Antiviral Society-USA Panel
    Thompson, Melanie A.
    Aberg, Judith A.
    Hoy, Jennifer F.
    Telenti, Amalio
    Benson, Constance
    Cahn, Pedro
    Eron, Joseph J., Jr.
    Guenthard, Huldrych F.
    Hammer, Scott M.
    Reiss, Peter
    Richman, Douglas D.
    Rizzardini, Giuliano
    Thomas, David L.
    Jacobsen, Donna M.
    Volberding, Paul A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (04): : 387 - 402